Similarly, CD47, which promotes immune evasion by engaging signal-regulatory protein alpha (SIRPα) and serves as an inhibitory receptor on macrophages, is emerging as a novel macrophage immune checkpoint for cancer immunotherapy 83. Here, SIRPA is linked to cancer.